don't do what

twitter is scary

[don't do what @danadontdoes]

@LuisSchang @herodowntown @HerpesAdvocate https://t.co/gEG7DwitwC

[don't do what @danadontdoes]

@LuisSchang @herodowntown @HerpesAdvocate Not true.

https://t.co/gEG7DwitwC

https://t.co/GSLTwCqsOT

[don't do what @danadontdoes]

@LuisSchang @herodowntown @HerpesAdvocate I am a scientist too. Always open to others’ ideas and interpretations even if they differ from my own. Follow up niclosamide trials have already been funded. Excited for future results.

[don't do what @danadontdoes]

@LuisSchang @herodowntown @HerpesAdvocate This is your opinion and that’s fine. No interest in spending the holiday fighting with strangers on a dying platform haha. Happy new year!

[don't do what @danadontdoes]

@LuisSchang @herodowntown @HerpesAdvocate Agreed. The study MAY have had an effect. Is misguided to rule this drug out completely based on one underpowered (but promising) study

[don't do what @danadontdoes]

@LuisSchang @herodowntown @HerpesAdvocate Authors stopped the study early for decreased enrollment/availability of unvaxx pops. Further study warranted.

[don't do what @danadontdoes]

@LuisSchang @herodowntown @HerpesAdvocate Respectfully disagree. That’s not how power calculations work at all. This study had 67 participants and was almost statistically significant.

[don't do what @danadontdoes]

@LuisSchang @herodowntown @HerpesAdvocate The published results actually did show activity. Niclosamide decreased viral shedding and duration of symptoms. Problem was small study size not the drug.

[don't do what @danadontdoes]

@DonEford @trailrunner402 @danaparish @POTUS True.

[don't do what @danadontdoes]

@trailrunner402 @DonEford @danaparish @POTUS Based on positive findings there are ongoing follow up studies but companies won’t fund off-patent drugs bc they can’t make profit. Covid is all about money.

[don't do what @danadontdoes]

@trailrunner402 @DonEford @danaparish @POTUS This wasn’t because the drug didn’t work. Many enrolled patients were asymptomatic/mild and resolved quickly diluting pool. Moderate cases saw reduction in symptoms (5 days) and contagiousness (3 days) with niclosamide.

[don't do what @danadontdoes]

@Anisopterid Actually the issue was that many enrolled patients were not very sick so niclosamide’s effect was muted. Ones with more moderate disease saw reduced contagiousness and symptoms with niclosamide

[don't do what @danadontdoes]

Chris Rock is Scientology’s new Oprah couch #Oscars #whatjusthappened

[don't do what @danadontdoes]

@P_McCulloughMD

[don't do what @danadontdoes]

@Gem_kiss @P_McCulloughMD https://t.co/pDWSEvmh6L

[don't do what @danadontdoes]

@P_McCulloughMD Reduced contagious period by over 2 days. Despite these positive signals authors had to tone down the language

[don't do what @danadontdoes]

@P_McCulloughMD Another repurposed antihelmintic: reduced symptomatic period by 5 days in high risk patients

[don't do what @danadontdoes]

@P_McCulloughMD Please read this study:

https://t.co/pDWSEvmh6L

[don't do what @danadontdoes]

@Aller_MD It was very close to achieving significance - small sample size. Reduction in symptom duration ~5 days in patients with moderate disease and higher risk